Alle Storys
Folgen
Keine Story von Clearview Projects, Inc. mehr verpassen.

Clearview Projects, Inc.

Jan Wolpert Joins Clearview Projects as President & CEO

Princeton, New Jersey, November 17 (ots/PRNewswire)

Clearview
Projects, Inc. announced today that Jan Wolpert has joined the
company as President & CEO. Most recently, Jan was the president,
founder and principal owner of Wolpert Associates, Inc., a strategic
management consulting firm specializing in corporate development
matters.
With offices in both New Jersey and California, Clearview Projects
provides biopharmaceutical companies with analytical and tactical
support for strategic business transactions, including
co-development/commercialization, in/out-licensing, and M&A activity.
Clearview also provides clients with strategic business assessments
including high level strategy development, portfolio analyses,
product forecasting, and asset valuations. Mr. Wolpert will work out
of the company's Princeton, New Jersey office.
Jan Wolpert has over 20 years of general management, corporate
development and strategic planning experience in the life sciences
industry and other industrial sectors. He has led the
conceptualization and execution of over 50 complex corporate
development transactions involving acquisitions, divestitures,
private and public company spin-offs, venture capital, public company
financings and alliances/licensing. An acknowledged expert on
corporate development initiatives, strategic planning and
restructuring matters, he has written for numerous business
publications and has been a panelist or speaker at many conferences.
While a Vice President of Corporate Business Development at
Pharmacia from 2000 to 2003 (now an affiliate of Pfizer) and as Vice
President of Venture Capital/Mergers & Acquisitions at its
predecessor Monsanto from 1996 to 2000, he directed the corporation's
aggressive restructuring and new venture activities. His managerial
and transaction leadership was instrumental in the formation of
numerous private companies, including Biovitrum AB
(biopharmaceuticals), Metaphore Pharmaceuticals (small molecule
drugs) and Mendel Biotechnology (functional genomics), and the
spin-off of Monsanto's former holdings in consumer packaged food,
food ingredients, nutritional biotechnology and advanced materials.
His past employers have included PricewaterhouseCoopers Consulting,
where he co-led the firm's New York City-based restructuring
practice. He holds an M.B.A. degree from The Wharton School and a
B.S. in electrical engineering from The University of Maryland at
College Park. Jan resides in northern New Jersey with his wife and
two sons.
For more information on Clearview Projects, Inc., please visit the
web site at www.clearviewprojects.com or contact Sam Barker via
phone: +1-609-580-3607 or email:  sbarker@clearviewprojects.com or Jan
Wolpert via phone: +1-609-580-3606 or e-mail: 
jwolpert@clearviewprojects.com.
Web site: http://www.clearviewprojects.com

Contact:

Sam Barker, +1-609-580-3607, or sbarker@clearviewprojects.com, or Jan
Wolpert, +1-609-580-3606 or jwolpert@clearviewprojects.com, both of
Clearview